Market Overview

Global Glucose Monitoring Devices Market 2016-2024: Quality Products at Low Prices - Mantra for Success in the Marketplace

Share:

Dublin, Aug. 22, 2018 (GLOBE NEWSWIRE) -- The "Glucose Monitoring Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Glucose Monitoring Devices in US$ by the following Product Segments:

  • Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, & Lancets)
  • Continuous Glucose Monitoring

The report profiles 77 companies including many key and niche players such as:

  • Abbott Diabetes Care, Inc. (USA)
  • ACON Laboratories, Inc. (USA)
  • AgaMatrix, Inc. (USA)
  • Alive Technologies Pty. Ltd. (Australia)
  • Apex Biotechnology Corp. (Taiwan)
  • ARKRAY, Inc. (Japan)
  • Arkray USA, Inc. (USA)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • B. Braun Melsungen AG (Germany)
  • Beurer GmbH (Germany)
  • BIONIME Corporation (Taiwan)
  • Dexcom, Inc. (USA)
  • Entra Health Systems LLC (USA)
  • GlySens Incorporated (USA)
  • LifeScan, Inc. (USA)
  • Medtronic plc (Ireland)
  • Medtronic MiniMed, Inc. (USA)
  • Nova Biomedical Corporation (USA)
  • Omron Healthcare Co., Ltd. (Japan)
  • Roche Diagnostics (Switzerland)
  • Sanofi S.A. (France)
  • Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
  • Senseonics Holdings, Inc. (USA)
  • Taidoc Technology Corporation (Taiwan)
  • Terumo Corporation (Japan)
  • Trividia Health, Inc. (USA)
  • Ypsomed Holding AG (Switzerland)

Key Topics Covered:

1. INDUSTRY OVERVIEW
Glucose Monitoring Devices: Enabling Easier and Efficient Monitoring of the Global Diabetes Epidemic
Growth Drivers in a Nutshell
Glucose Monitoring Undergoes Notable Transformation over the Years: An Evolutionary Scan
Evolution of Diabetes Testing over the Years with Key Features in Each Period
Diabetes Incidence Reaching Epidemic Proportions Worldwide: Foundation for Market Growth
Diabetes: One of the Leading Causes of Death Globally
Diabetes Incidence and Prevalence by Region/Country
Global Market Outlook
Developed Countries are Dominant Markets, while Developing Countries Spearhead Market Growth

2. COMPETITION
The Big Four' Dominate the Global Self Glucose Monitoring (SGM) Market
Major Pharma Players Dominate Blood Glucose Monitoring Market
Innovations in BGM Devices Spearheaded by Startups
Competition with Local Pharma Companies Intensifies in Regional Markets
Quality Products at Low Prices: Mantra for Success in the Marketplace
After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move
Dexcom and Medtronic Dominates the Global CGM Devices Market

3. MARKET TRENDS, ISSUES AND DRIVERS
Growing Popularity of Smart, Compact, Digital, Ergonomic, and Wireless Glucose Monitors Drive Healthy Market Growth
Select Disruptive Glucose Monitors Promising Innovative Smart Glucometers for Sugar Monitoring
Need for Real-Time Glucose Sensing and Monitoring Drive Strong Demand for Minimally-Invasive CGM Devices
Myriad Benefits of CGMs
CGM Market Gradually Breaks through Barriers to Adoption
Intensive Care Units: A Highly Promising Market for CGMs
Key Challenges Hampering Widespread Adoption of CGM Systems
Despite Competition from CGM Systems, SGM Devices Continue to Dominate Sales
Blood Glucose Test Strips: The Largest Segment
Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand
Key Trends in the Glucose Meter/Monitoring Systems
Smartphone Penetration Favors SMBG Market
Barriers to Adoption of New Technology in BGM Products
Accuracy Issues Plague Blood Glucose Meters Market
Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
Increased Vulnerability of Diabetics to Various Health Complications Drives the Need for Timely Glucose Monitoring
Heart Disease
Stroke
High Blood Pressure
Blindness
Kidney Disease
Nerve Disease
Amputations
Dental Disease
Pregnancy
Microvascular Complications (Small Blood Vessel Damage)
Macrovascular Complications (Large Blood Vessel Damage)
Infections
Impotence
Pregnancy Complications
Other Complications Resulting from Diabetes
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
Higher Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
Increasing Healthcare Expenditure Boosts Demand for SGM and CGM Devices
Expenditure on Diabetes Management
Increasing Obesity Levels Underpins Market Growth

4. INNOVATIONS & ADVANCEMENTS
K'Track: Discreet and Painless Glucose- Monitoring Wearable
The Sugar iQ App Provide Predictive Diabetes Care
DIABNEXT CLIPSULIN: World's First A.I Tool for Diabetes
e-mosquito CGM Device
FreeStyle Libre Flash Glucose Monitoring System
MyDario Mobile Data Management Platform
The New Handheld RL-BGM Device
TOUCH TG
Pocket-Sized Gadgets
Digital Contact Lenses
Gamification
Leveraging Big Data
Digital Tattoos
OneTouch Verio Flex Monitoring System
Artificial Pancreas System (APS): The Next Big Thing in Glucose Monitoring
The First-of-its-Kind Artificial Pancreas by Medtronic
Non-invasive, Acetone Detecting Breathalyzer for Glucose Testing
Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring
EMG 1000: Needle-free Device for Glucose Monitoring
Glucase: Smartphone Case with Glucose Testing Kit
Painless Diabetes Monitoring Using NFC Technology
GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels
ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes
NoStrip Technology: Eliminating Need for Individual Test Strips
Other Innovative and Advanced Glucose Monitoring Systems
GlucoTrack
A2I
Omnipod Horizon
V-Go
sugarBEAT
G5 Integrated Vibe Insulin Pump and CGM System
FreeStyle Libre and FreeStyle Libre Pro
Contour Next One and Contour Next Link
Bewell Connects
Biosensor-based Monitor called Lumee
Touchscreen Receiver/Android App
OneTouch Via
MiniMed 670G/Enlite 3 with Hybrid Closed Loop
Dexcom G5 Mobile CGM with Bluetooth
Dario-Smart Meter from LabStyle
Notable Early-stage Investigative Glucose Monitoring Devices

5. PRODUCT OVERVIEW

6. PRODUCT INNOVATIONS/INTRODUCTIONS
ARKRAY Releases PocketChem VC PV-1350on Reducing Substances Meter
ARKRAY Releases BG Sensor
The U.S. Food and Drug Administration Approves Abbott' Glucose Monitoring Device
ARKRAY Releases Glycohemoglobin Analyzer ADAMS A1c HA-8190V
Intel Releases New Software Application Platform, IntelHAP
ARKRAY Releases GLUCOCARD W Blood Glucose Meter
Abbott's FreeStyle Libre Pro System Receives FDA Approval
Roche Launches Accu-Chek Guide System
Ascensia Launches CONTOURNEXT LINK 2.4 Blood Glucose Monitoring System (BGMS)
ACON Laboratories Launches On Call Pro Blood Glucose Meter
LifeScan Introduces OneTouch Verio Flex

7. RECENT INDUSTRY ACTIVITY
AgaMatrix Inc. Enters into a $32 Million Senior Term Loan Facility with Prospect
Fitbit Partners with Dexcom
Abbott Enters into Collaboration with Bigfoot Biomedical
Roche Acquires mySugr
Abbott Obtains the Health Canada License for FreeStyle Libre Flash Glucose Monitoring System
Roche Signs a Partnership Agreement with Medtronic
TGA Approves for Abbott's FreeStyle Libre System
Glooko and Diasend Enter into Merger
BioTelemetry Acquires Telcare Medical Supply
Mitsui to Acquire Shares in Panasonic Healthcare Holdings
ARKRAY Collaborates with LG Life Sciences Ltd.
Ascensia Diabetes Care Renews Global Alliance with Medtronic
Senseonics Signs Distribution Agreement with Roche
Dexcom G5 Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch
Cellnovo Signs a Commercial Agreement with Roche
Nemaura' sugarBEAT Receives Notification of CE Approval
Tekcapital PLC Acquires the License for the Measurement of Glucose in Saliva
Abbott Obtains CE Mark for the FreeStyle Libre System
Nova Biomedical's StatStrip Glucose Xpress 2 Receives FDA Clearance
Sinocare Acquires Nipro Diagnostics Inc.
LabStyle's Dario System Receives FDA Clearance
Panasonic Healthcare Acquires the Bayer Diabetes Care Business

8. FOCUS ON SELECT GLOBAL PLAYERS

9. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 77 (including Divisions/Subsidiaries 89)

  • The United States (38)
  • Canada (2)
  • Japan (5)
  • Europe (24)
    • France (1)
    • Germany (4)
    • The United Kingdom (6)
    • Italy (1)
    • Rest of Europe (12)
  • Asia-Pacific (Excluding Japan) (18)
  • Middle East (1)
  • Latin America (1)

For more information about this report visit https://www.researchandmarkets.com/research/hr5b6n/global_glucose?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Glucose Testing, Diabetes Devices 

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
SCCOBradescoUpgrades42.0
PFODFJefferiesUpgrades0.0
TEDUJefferiesDowngrades5.8
INVVYJefferiesDowngrades0.0
UMPQPiperJaffrayUpgrades20.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.